The Swiss National Research Programme NRP 63 recently featured Xeltis’ technology and the story of Dominika – the first patient treated with a Xeltis’ device – in an online article. NRP 63 is focusing on stem cells and regenerative medicine with the purpose of providing a boost to basic research in the field. Funded by the Swiss National Science Foundation, the National Research Programmes support research projects that contribute solutions to problems of national significance.
